The CrossCheck study will include 150
schizophrenic patients who have been discharged
from Zucker Hillside Hospital, in
Glen Oaks, within the past year. Half of
those patients will receive smartphones
with the app, while the other half, the control
group, will receive the standard clinical
services that the hospital provides after
a patient is discharged. To see if the app
leads to better outcomes, “we’ll be looking
at the time lag between when they’re
recruited and their first relapse, and also
at the number of relapses they have over
a year,” Ben-Zeev explains.